
Top Picks
Contineum Therapeutics Inc (CTNM)’s latest performance is not what we had anticipated
On Tuesday, Contineum Therapeutics Inc (NASDAQ: CTNM) was 14.81% up from the session before settling in for the closing price of $8.1. A 52-week range